|
Anticonvulsants Market ForecastPublished by: Datamonitor Published: Oct. 8, 2009 - 125 Pages Table of Contents
AbstractIntroductionIn 2008, seven major market sales of anticonvulsants reached $13.6 billion, making it one of the largest therapeutic drug classes in the Pharmaceutical sector. However, generic incursion of second generation anticonvulsants will continue to increase the barrier to entry for prospective players, although viable commercial opportunities exist to optimize returns from this lucrative drug class market Reasons to Purchase
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||